Latest Sales Growth News

Challenger Limited reported a solid 4% increase in total Life sales to $2.5 billion in Q1 FY26, buoyed by strong annuity sales and strategic partnerships. The company reaffirmed its FY26 earnings guidance while highlighting upcoming regulatory changes expected to benefit the sector.

Baby Bunting has reported record FY25 results and reaffirmed its FY26 guidance, driven by strong sales growth and the ongoing Store of the Future refurbishment program. The company is expanding both large and small format stores, aiming to return to a +10% EBITDA margin business.

OMG Group has completed a strategic integration with Shiperoo, enhancing its supply chain to meet rising demand from major Australian retailers and ecommerce channels. This move supports recent product expansions and aims to drive cost efficiencies and scalability.

Immuron Limited reports a robust 34% year-on-year sales increase for Q1 FY26, driven by strong growth in Australia and the USA, while Canadian sales dip seasonally. The company’s marketing efforts and expanding retail presence underpin this momentum.

DroneShield’s DroneSentry counterdrone system has earned official recognition from the UK’s National Protective Security Authority, boosting its credibility and market potential amid rising drone threats.

Guzman y Gomez reports robust Q1 FY26 sales growth and network expansion, alongside a significant $100 million share buyback to enhance shareholder value.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

Redox Limited reported a 9.4% increase in sales revenue for FY25 despite challenging global conditions, while declaring a robust dividend payout that exceeds its policy. The company’s strategic focus on specialty chemicals, operational expansion, and ESG commitments positions it well for continued growth.

Summerset Group has achieved its highest-ever quarterly sales of occupation rights, driven by strong demand for care-related living options and steady growth beyond major cities.

Hydralyte USA reports an 11% sales increase in Q3 2025, driven by strong summer demand and the launch of its innovative Hydralyte Plus Brain Support product featuring nootropics.

OMG Group Limited has reported a remarkable 114% year-on-year increase in net sales for Q1 FY26, driven by robust ecommerce growth and expanding retail partnerships.

Biome Australia Limited has reported a record-breaking $5.94 million in sales revenue for Q1 FY26, surpassing forecasts and accelerating toward its ambitious Vision 27 revenue goals.